Listed

HCA Healthcare, Inc.

HCANYSECIK 860730HealthcareFiscal year ends Dec 31

Reports and events: 370 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

HCA Healthcare, Inc., Reports and events
FiledFormWhat it isAccession number
2024-02-2316:31 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-24-044555
2024-02-2108:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-040747
2024-02-1617:03 ET10-KAnnual reportPeriod 2023-12-310000950170-24-016524
2024-01-3008:01 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-018748
2023-11-0907:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-274071
2023-10-2616:30 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-055641
2023-10-2408:27 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-261204
2023-08-0216:32 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-037237
2023-07-2707:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-195360
2023-07-1009:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-184269
2023-05-2616:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-155487
2023-05-0416:55 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-23-136049
2023-05-0209:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-131536
2023-04-2716:31 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-015314
2023-04-2116:29 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-110578
2023-04-2107:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-109258
2023-04-0616:59 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-094138
2023-03-1016:28 ETDEF 14AProxy statement0001193125-23-067645
2023-02-1717:12 ET10-KAnnual reportPeriod 2022-12-310000950170-23-003234
2023-01-3016:36 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-23-019137
2023-01-2707:37 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-016833
2023-01-0417:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-001579
2022-12-1916:42 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-22-308372
2022-11-0116:31 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-020865
2022-10-2616:25 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-269593
2022-10-2107:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-266319
2022-08-1708:34 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-222847
2022-08-0116:31 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-013683
2022-07-2207:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-199606
2022-05-2620:28 ET8-K8.01 Other events0001193125-22-160031
2022-05-0316:31 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-007089
2022-04-2617:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-22-120439
2022-04-2208:11 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-114235
2022-04-1116:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-101742
2022-04-0716:44 ET8-K8.01 Other events0001193125-22-098964
2022-03-1116:25 ETDEF 14AProxy statementPeriod 2022-04-210001193125-22-073436
2022-03-1021:56 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-22-070987
2022-03-0308:41 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-063719
2022-03-0216:43 ET8-K8.01 Other events0001193125-22-063063
2022-03-0209:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-062405
2022-02-1817:01 ET10-KAnnual reportPeriod 2021-12-310001193125-22-046707
2022-01-2708:18 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-019075
2021-11-0116:30 ET10-QQuarterly reportPeriod 2021-09-300001193125-21-315476
2021-10-2716:47 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-309426
2021-10-2207:34 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-304715
2021-08-0216:37 ET10-QQuarterly reportPeriod 2021-06-300001193125-21-233345
2021-07-2708:39 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-225096
2021-07-2008:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-219158
2021-07-0121:42 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-21-205276
2021-06-2207:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-195711

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.